The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Open accessAbstract
Cancer cells adapt their metabolic processes to drive macromolecular biosynthesis for rapid cell growth and proliferation. RNA interference (RNAi)-based loss-of-function screening has proven powerful for the identification of new and interesting cancer targets, and recent studies have used this technology in vivo to identify novel tumour suppressor genes. Here we developed a method for identifying novel cancer targets via negative-selection RNAi screening using a human breast cancer xenograft model at an orthotopic site in the mouse. Using this method, we screened a set of metabolic genes associated with aggressive breast cancer and stemness to identify those required for in vivo tumorigenesis. Among the genes identified, phosphoglycerate dehydrogenase (PHGDH) is in a genomic region of recurrent copy number gain in breast cancer and PHGDH protein levels are elevated in 70% of oestrogen receptor (ER)-negative breast cancers. PHGDH catalyses the first step in the serine biosynthesis pathway, and breast cancer cells with high PHGDH expression have increased serine synthesis flux. Suppression of PHGDH in cell lines with elevated PHGDH expression, but not in those without, causes a strong decrease in cell proliferation and a reduction in serine synthesis. We find that PHGDH suppression does not affect intracellular serine levels, but causes a drop in the levels of α-ketoglutarate, another output of the pathway and a tricarboxylic acid (TCA) cycle intermediate. In cells with high PHGDH expression, the serine synthesis pathway contributes approximately 50% of the total anaplerotic flux of glutamine into the TCA cycle. These results reveal that certain breast cancers are dependent upon increased serine pathway flux caused by PHGDH overexpression and demonstrate the utility of in vivo negative-selection RNAi screens for finding potential anticancer targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Functional PHGDH loss is toxic to tumor cells with PHGDH amplification or high serine biosynthetic flux (Locasale et al., 2011; Mattaini et al., 2015; Possemato et al., 2011; Zhang et al., 2017), and small-molecule inhibitors targeting PHGDH have been shown to inhibit serine synthesis and tumor proliferation in vitro and in xenograft cancer models (Mullarky et al., 2016; Pacold et al., 2016; Wang”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“Serine is present in plasma and can be taken up by cells via amino acid transporters, yet PHGDH expression and increased serine biosynthesis have been shown to be important for supporting cancer cell proliferation and survival in both in vitro and in vivo settings (Locasale et al., 2011; Possemato et al., 2011).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“Increased PHGDH gene expression leads to greater production of serine from glucose and is associated with specific subsets of breast cancer, lung adenocarcinoma, and melanoma (Locasale et al., 2011; Possemato et al., 2011; Zhang et al., 2017).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“More recently, it was found that increased expression of the serine synthesis enzyme phosphoglycerate dehydrogenase (PHGDH) in some cancers can result from copy number gain of a region on chromosome 1p (Beroukhim et al., 2010; Locasale et al., 2011; Possemato et al., 2011) or a consequence of oncogenic signaling, including NRF2 and ATF4 signaling (DeNicola et al., 2015), or hypoxia responses (Sam”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Possemato et al., 2011
In the citing paper
“A rate-limiting serine biosynthesis enzyme, 3-phosphoglycerate dehydrogenase (PHGDH), is frequently focally amplified in breast cancer and melanoma and is required for the growth of PHGDH-amplified cells in vitro as well as in vivo”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Possemato et al., 2011
In the citing paper
“Amplification of PHGDH has been observed in breast cancer and melanoma (65), and increased PHGDH expression can promote both enhanced serine biosynthesis and the proliferation of cancer cells (65, 66).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [66]
In the citing paper
“the region of chromosome 1p12 encoding PHGDH is amplified in a significant fraction of tumors”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Possemato et al., 2011
In the citing paper
“cell lines derived from these tumors tend to be highly dependent on PHGDH expression”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Possemato et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., Veer, L. V. ‘., Dai, H. A., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,474
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Self-citationDeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Ben‐Porath, I., Thomson, M., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,571
Sancak, Y., Bar-Peled, L., Zoncu, R., Markhard, A. L., Nada, S., & Sabatini, D. M. (2010) · Cell · doi:10.1016/j.cell.2010.02.024 · Cited by 2,464
Self-citationCancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 2×
“Cancer cells adapt their metabolic processes to drive macromolecular biosynthesis for rapid cell growth and proliferation (1,2).”
Self-citationRhodes, D. R., Sundaram, S. K., Mahavisno, V., Varambally, R., Yu, J., Briggs, B., Barrette, T. R., Anstett, M. J., Kincead-Beal, C., Kulkarni, P., et al. (2007) · Neoplasia · doi:10.1593/neo.07112 · Cited by 2,057
A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,804
Self-citationDissecting direct reprogramming through integrative genomic analysis
Mikkelsen, T. S., Hanna, J. H., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B., Jaenisch, R., Lander, E. S., & Meissner, A. (2008) · Nature · doi:10.1038/nature07056 · Cited by 1,515
Connecting microRNA Genes to the Core Transcriptional Regulatory Circuitry of Embryonic Stem Cells
Marson, A., Levine, S. S., Cole, M. F., Frampton, G. M., Brambrink, T., Johnstone, S. E., Guenther, M. G., Johnston, W. K., Wernig, M., Newman, J. J., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.020 · Cited by 1,405
Cited by
Sorted by citations
Items 301–400 of 1,000
The Janus-like role of proline metabolism in cancer
Burke, L. E. C.-A., Guterman, I., Palacios-Gallego, R., Britton, R. G., Burschowsky, D., Tufarelli, C., & Rufini, A. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00341-8 · Cited by 131
Global Profiling Strategies for Mapping Dysregulated Metabolic Pathways in Cancer
Benjamin, D. I., Cravatt, B. F., & Nomura, D. K. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.09.013 · Cited by 131
2-Hydroxyglutarate in Cancer Cells
Ježek, P. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7902 · Cited by 130
Chinopoulos, C., & Seyfried, T. N. (2018) · ASN NEURO · doi:10.1177/1759091418818261 · Cited by 130
Kindlin-2 links mechano-environment to proline synthesis and tumor growth
Guo, L., Cui, C., Zhang, K., Wang, J., Wang, Y., Lu, Y., Chen, K., Yuan, J., Xiao, G., Tang, B. H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08772-3 · Cited by 130
Regulation of glycolysis and the Warburg effect by estrogen-related receptors
Cai, Q., Lin, T., Kamarajugadda, S., & Lu, J. (2012) · Oncogene · doi:10.1038/onc.2012.221 · Cited by 129
Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer
Jin, N., Bi, A., Lan, X., Xu, J., Wang, X., Liu, Y., Wang, T., Tang, S., Zeng, H., Chen, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10427-2 · Cited by 129
Nuclear metabolism and the regulation of the epigenome
Boon, R., da Silveira, G. G., & Mostoslavsky, R. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00285-4 · Cited by 129
Extracellular serine controls epidermal stem cell fate and tumour initiation
Baksh, S. C., Todorova, P. K., Gur-Cohen, S., Hurwitz, B., Ge, Y., Novak, J. S. S., Tierney, M. T., dela Cruz-Racelis, J., Fuchs, E., & Finley, L. W. S. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0525-9 · Cited by 128
Reprogramming of serine, glycine and one-carbon metabolism in cancer
Li, A. M., & Ye, J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165841 · Cited by 127
MERAV: a tool for comparing gene expression across human tissues and cell types
Shaul, Y. D., Yuan, B., Thiru, P., Nutter-Upham, A., McCallum, S., Lanzkron, C., Bell, G. W., & Sabatini, D. M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1337 · Cited by 127
Self-citationAmplification of USP13 drives ovarian cancer metabolism
Han, C., Yang, L., Choi, H. H., Baddour, J., Achreja, A., Liu, Y., Li, Y., Li, J., Wan, G., Huang, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms13525 · Cited by 127
Glucose Metabolism in Pancreatic Cancer
Liang, Y., Raj, P. S., Yao, W., & Ying, H. (2019) · Cancers · doi:10.3390/cancers11101460 · Cited by 128
p73 regulates serine biosynthesis in cancer
Amelio, I., Markert, E. K., Rufini, A., Antonov, A. V., Sayan, B. S., Tucci, P., Agostini, M., Mineo, T. C., Levine, A. J., & Melino, G. (2013) · Oncogene · doi:10.1038/onc.2013.456 · Cited by 126
Angiogenesis Revisited: An Overlooked Role of Endothelial Cell Metabolism in Vessel Sprouting
Vandekeere, S., Dewerchin, M. A., & Carmeliet, P. (2015) · Microcirculation · doi:10.1111/micc.12229 · Cited by 126
Stalling the Engine of Resistance: Targeting Cancer Metabolism to Overcome Therapeutic Resistance
Butler, E. B., Zhao, Y., Muñoz‐Pinedo, C., Lu, J., & Tan, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3009 · Cited by 126
The complexity of the serine glycine one-carbon pathway in cancer
Reina‐Campos, M., Díaz-Meco, M. T., & Moscat, J. (2019) · The Journal of Cell Biology · doi:10.1083/jcb.201907022 · Cited by 125
ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer
Deblois, G., Smith, H. W., Tam, I. S., Gravel, S., Caron, M., Savage, P., Labbé, D. P., Bégin, L. R., Tremblay, M. L., Park, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12156 · Cited by 124
Muir, A., Danai, L. V., & Heiden, M. G. V. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035758 · Cited by 124
Crosstalk between Estrogen Signaling and Breast Cancer Metabolism
Kulkoyluoglu‐Cotul, E., Blanco, A. A., & Madak‐Erdogan, Z. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.10.006 · Cited by 124
Phosphatidic acid and lipid-sensing by mTOR
Foster, D. A. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.02.003 · Cited by 124
Liu, J., Guo, S., Li, Q., Yang, L., Xia, Z.-B., Zhang, L., Huang, Z., & Zhang, N. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-1018-x · Cited by 122
Serine Metabolism: Some Tumors Take the Road Less Traveled
DeBerardinis, R. J. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.004 · Cited by 121
Liu, X., Liu, Y., Liu, Z., Lin, C., Meng, F., Xu, L., Zhang, X., Zhang, C., Zhang, P., Gong, S., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01412-9 · Cited by 121
Parkin Regulates the Activity of Pyruvate Kinase M2
Liu, K., Li, F., Han, H., Chen, Y., Mao, Z., Luo, J., Zhao, Y., Zheng, B., Gu, W. J., & Zhao, W. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.703066 · Cited by 121
Amino acid management in cancer
Tsun, Z.-Y., & Possemato, R. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.08.002 · Cited by 120
Self-citationEnergy disruptors: rising stars in anticancer therapy?
Bost, F., Poullot, A. G., Tanti, J., & Clavel, S. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.46 · Cited by 119
Compartmentalized metabolism supports midgestation mammalian development
Solmonson, A., Faubert, B., Gu, W., Rao, A. D., Cowdin, M. A., Menendez-Montes, I., Kelekar, S., Rogers, T. J., Pan, C., Guevara, G., et al. (2022) · Nature · doi:10.1038/s41586-022-04557-9 · Cited by 119
Vučetić, M., Cormerais, Y., Parks, S. K., & Pouysségur, J. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00319 · Cited by 121
Endothelial cell metabolism: parallels and divergences with cancer cell metabolism
Verdegem, D., Moens, S., Stapor, P. C., & Carmeliet, P. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-19 · Cited by 117
Newman, A. C., Falcone, M., Uribe, A. H., Zhang, T., Athineos, D., Pietzke, M., Vázquez, A., Blyth, K., & Maddocks, O. D. K. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.03.019 · Cited by 117
Li, L., Wei, Y., To, C., Zhu, C., Tong, J., Pham, N., Taylor, P. P., Ignatchenko, V., Ignatchenko, A., Zhang, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms6469 · Cited by 116
Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer
Dennison, J. B., Molina, J. R., Mitra, S., Gonzalez-Angulo, A. M., Balko, J. M., Kuba, M. G., Sanders, M. E., Pinto, J. A., Gómez, H., Arteaga, C. L., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0623 · Cited by 116
Montrose, D. C., Saha, S., Foronda, M., McNally, E. M., Chen, J. B., Zhou, X. K., Ha, T., Krumsiek, J., Büyüközkan, M., Verma, A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1541 · Cited by 116
Nonessential amino acid metabolism in breast cancer
Geck, R. C., & Toker, A. (2016) · Advances in Biological Regulation · doi:10.1016/j.jbior.2016.01.001 · Cited by 115
p53 regulates glucose metabolism by miR-34a
Kim, H.-R., Roe, J., Lee, J., Cho, E., & Youn, H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.043 · Cited by 115
Glutamine‐fueled mitochondrial metabolism is decoupled from glycolysis in melanoma
Filipp, F. V., Ratnikov, B. I., Ingeniis, J. D., Smith, J. W., Osterman, A. L., & Scott, D. A. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12000 · Cited by 115
Profiling metabolic networks to study cancer metabolism
Hiller, K., & Metallo, C. M. (2012) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2012.11.001 · Cited by 113
Epigenetics and cancer metabolism
Johnson, C., Warmoes, M. O., Shen, X., & Locasale, J. W. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.09.043 · Cited by 113
Rinaldi, G., Pranzini, E., Elsen, J. V., Broekaert, D., Funk, C. M., Planque, M., Doglioni, G., Altea‐Manzano, P., Rossi, M., Geldhof, V., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.11.027 · Cited by 113
Yu, T., Ma, D., Liu, Y., Xiao, Y., Gong, Y., Jiang, Y., Shao, Z.-M., Hu, X., & Di, G. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.03.003 · Cited by 113
Fan, G., Yu, B., Tang, L., Zhu, R., Chen, J., Zhu, Y., Huang, H., Zhou, L., Liu, J., Wang, W., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adj5705 · Cited by 116
Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1
Wang, S., Jiang, B., Zhang, T., Liu, L., Wang, Y., Wang, Y., Chen, X., Lin, H., Zhou, L., Xia, Y., et al. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002243 · Cited by 112
Organ-Specific Cancer Metabolism and Its Potential for Therapy
Elia, I., Schmieder, R., Christen, S., & Fendt, S. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_10 · Cited by 112
Formate: The Neglected Member of One-Carbon Metabolism
Brosnan, M. E., & Brosnan, J. T. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050738 · Cited by 112
Serine biosynthesis and transport defects
El‐Hattab, A. W. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.04.010 · Cited by 111
Metabolism and epigenetics: a link cancer cells exploit
Carrer, A., & Wellen, K. E. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.11.012 · Cited by 110
Lin, K., Xie, A., Rutter, J. C., Ahn, Y.-R., Lloyd-Cowden, J. M., Nichols, A., Soderquist, R. S., Koves, T. R., Muoio, D. M., MacIver, N. J., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.011 · Cited by 110
Complex roles of nicotinamide N-methyltransferase in cancer progression
Wang, W., Yang, C., Wang, T., & Deng, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04713-z · Cited by 110
PSAT1 regulates cyclin D1 degradation and sustains proliferation of non‐small cell lung cancer cells
Yang, Y., Wu, J., Cai, J., He, Z., Yuan, J. X., Zhu, X., Li, Y., Li, M., & Guan, H. (2014) · International Journal of Cancer · doi:10.1002/ijc.29150 · Cited by 109
Molecular Pathways: Targeting MYC-induced Metabolic Reprogramming and Oncogenic Stress in Cancer
Li, B., & Simon, M. C. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3629 · Cited by 108
The Metabolic Alterations of Cancer Cells
Sciacovelli, M., Gaude, E., Hilvo, M., & Frezza, C. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416618-9.00001-7 · Cited by 108
Beyond the Warburg effect: How do cancer cells regulate one-carbon metabolism?
Rosenzweig, A., Blenis, J., & Gomes, A. P. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00090 · Cited by 107
Plasma-free amino acid profiles are predictors of cancer and diabetes development
Bi, X., & Henry, C. J. (2017) · Nutrition and Diabetes · doi:10.1038/nutd.2016.55 · Cited by 107
ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer
Li, K., Wu, J., Qin, B., Fan, Z.-M., Tang, Q., Lu, W., Zhang, H., Xing, F., Meng, M., Zou, S., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0257-1 · Cited by 107
Amino Acid Metabolism in Cancer Drug Resistance
Yoo, H.-C., & Han, J. M. (2022) · Cells · doi:10.3390/cells11010140 · Cited by 107
Giardina, G., Brunotti, P., Fiascarelli, A., Cicalini, A., Costa, M. G. S., Buckle, A. M., di Salvo, M. L., Giorgi, A., Marani, M., Paone, A., et al. (2015) · FEBS Journal · doi:10.1111/febs.13211 · Cited by 107
l-Serine links metabolism with neurotransmission
Maugard, M., Vigneron, P.-A., Bolaños, J. P., & Bonvento, G. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101896 · Cited by 106
Pranzini, E., Pardella, E., Muccillo, L., Leo, A., Nesi, I., Santi, A., Parri, M., Zhang, T., Uribe, A. H., Lottini, T., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111233 · Cited by 106
Systems biology analysis of drivers underlying hallmarks of cancer cell metabolism
Zielinski, D. C., Jamshidi, N., Corbett, A. J., Bordbar, A., Thomas, A., & Palsson, B. Ø. (2017) · Scientific Reports · doi:10.1038/srep41241 · Cited by 106
Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells
Zheng, L., MacKenzie, E. D., Karim, S. A., Hedley, A., Blyth, K., Kalna, G., Watson, D. G., Szlosarek, P., Frezza, C., & Gottlieb, E. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-12 · Cited by 103
Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer
Lukey, M. J., Cluntun, A. A., Katt, W. P., Lin, M.-C. J., Druso, J. E., Ramachandran, S., Erickson, J. W., Le, H. H., Wang, Z.-E., Blank, B., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.076 · Cited by 103
Regulatory mechanisms of one-carbon metabolism enzymes
Petrova, B., Maynard, A. G., Wang, P., & Kanarek, N. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105457 · Cited by 103
Zhang, Y., Yu, H. T., Zhang, J., Gao, H., Wang, S., Li, S., Wei, P., Liang, J., Yu, G., Wang, X., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146187 · Cited by 103
Cancer Metabolism: Fueling More than Just Growth
Lee, N., & Kim, D. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0310 · Cited by 102
Self-citationDong, J.-K., Lei, H.-M., Liang, Q., Tang, Y., Zhou, Y., Wang, Y., Zhang, S., Li, W., Tong, Y., Zhuang, G., et al. (2018) · Theranostics · doi:10.7150/thno.23177 · Cited by 102
Bonagas, N., Gustafsson, N., Henriksson, M., Marttila, P., Gustafsson, R., Wiita, E., Borhade, S. R., Green, A. C., Vallin, K. S. A., Sarno, A., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00331-y · Cited by 104
Metabolism in cancer metastasis
Weber, G. F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29839 · Cited by 102
¹H NMR-based metabolic profiling of human rectal cancer tissue
Wang, H., Wang, L., Zhang, H., Deng, P., Chen, J., Zhou, B., Hu, J., Zou, J., Lu, W., Pu, X., et al. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-121 · Cited by 102
Kondaveeti, Y., Reed, I. K. G., & White, B. A. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.025 · Cited by 101
The long noncoding RNA glycoLINC assembles a lower glycolytic metabolon to promote glycolysis
Zhu, Y., Jin, L., Shi, R., Li, J., Wang, Y., Zhang, L., chao-zhao, L., Narayana, V. K., Souza, D. P. D., Thorne, R. F., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2021.11.017 · Cited by 101
Lone, M. A., Santos, T. C. B., Alecu, I., Silva, L. C., & Hornemann, T. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.12.013 · Cited by 101
Ananieva, E. A., Patel, C. H., Drake, C. H., Powell, J. D., & Hutson, S. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554113 · Cited by 101
Esaki, K., Sayano, T., Sonoda, C., Akagi, T., Suzuki, T., Ogawa, T., Okamoto, M., Yoshikawa, T., Hirabayashi, Y., & Furuya, S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.603860 · Cited by 100
Liu, S., Sun, Y., Jiang, M., Li, Y., Tian, Y., Xue, W., Ding, N., Sun, Y., Cheng, C., Li, J., et al. (2017) · Hepatology · doi:10.1002/hep.29202 · Cited by 100
Keshet, R., Lee, J. S., Adler, L. N., Iraqi, M., Ariav, Y., Lim, L. Q. J., Lerner, S., Rabinovich, S., Oren, R., Katzir, R., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0106-7 · Cited by 100
Kim, S. K., Jung, W. H., & Koo, J. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101004 · Cited by 100
Ross, K. C., Andrews, A. J., Marion, C. D., Yen, T. J., & Bhattacharjee, V. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0798 · Cited by 99
Yun, H. J., Li, M., Guo, D. S., Jeon, S. M., Park, S. H., Lim, J. S., Lee, S. B., Liu, R. R., Du, L., Kim, S., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02927-3 · Cited by 99
Flux balance analysis predicts essential genes in clear cell renal cell carcinoma metabolism
Gatto, F., Miess, H., Schulze, A., & Nielsen, J. (2015) · Scientific Reports · doi:10.1038/srep10738 · Cited by 99
ATF3 promotes the serine synthesis pathway and tumor growth under dietary serine restriction
Li, X., Gracilla, D., Cai, L., Zhang, M., Yu, X., Chen, X., Zhang, J., Long, X., Ding, H.-F., & Yan, C. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109706 · Cited by 98
Clinical significance of T cell metabolic reprogramming in cancer
Herbel, C., Patsoukis, N., Bardhan, K., Seth, P., Weaver, J. D., & Boussiotis, V. A. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0110-9 · Cited by 99
Wilson, J. L., Nägele, T., Linke, M., Demel, F., Fritsch, S. D., Mayr, H. K., Cai, Z., Katholnig, K., Sun, X., Fragner, L., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.011 · Cited by 97
Systematic Identification of Barriers to Human iPSC Generation
Qin, H., Diaz, A. A., Blouin, L., Lebbink, R. J., Patena, W., Tanbun, P., LeProust, E. M., McManus, M. T., Song, J. S., & Ramalho‐Santos, M. (2014) · Cell · doi:10.1016/j.cell.2014.05.040 · Cited by 97
Glutamine‐utilizing transaminases are a metabolic vulnerability of TAZ/YAP‐activated cancer cells
Yang, C., Stampouloglou, E., Kingston, N. M., Zhang, L., Monti, S., & Varelas, X. (2018) · EMBO Reports · doi:10.15252/embr.201643577 · Cited by 97
Ma, X., Li, B., Liu, J., Fu, Y., & Luo, Y. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1053-y · Cited by 97
Liu, J., Zhang, C., Wu, H., Sun, X., Li, Y., HUANG, S. H., Yue, X., Lu, S., Shen, Z., Su, X., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci132876 · Cited by 98
A dried blood spot mass spectrometry metabolomic approach for rapid breast cancer detection
Cao, Y., Wang, Q., Gao, P., Dong, J., Zhu, Z., Fang, Y., Fang, Z., Sun, X., & Sun, T. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s95862 · Cited by 96
Palombo, V., Milanesi, M., Sgorlon, S., Capomaccio, S., Mele, M. L., Nicolazzi, E. L., Ajmone‐Marsan, P., Pilla, F., Stefanon, B., & D’Andrea, M. (2018) · Journal of Dairy Science · doi:10.3168/jds.2018-14413 · Cited by 96
Serine and one-carbon metabolism, a bridge that links mTOR signaling and DNA methylation in cancer
Zeng, J., Wu, W. K. K., Wang, H., & Li, X. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104352 · Cited by 96
The Intercellular Metabolic Interplay between Tumor and Immune Cells
Wang, T., Liu, G., & Wang, R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00358 · Cited by 96
Fan, T. W. ‐., Bruntz, R. C., Yang, Y., Song, H., Chernyavskaya, Y., Deng, P., Zhang, Y., Shah, P. P., Beverly, L. J., Qi, Z., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008743 · Cited by 95
Defining a metabolic landscape of tumours: genome meets metabolism
Nanda, C. S., Venkateswaran, S. V., Patani, N., & Yuneva, M. O. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0663-7 · Cited by 95
ONE-CLASS DETECTION OF CELL STATES IN TUMOR SUBTYPES
Sokolov, A., Paull, E., & Stuart, J. M. (2015) · Pacific Symposium on Biocomputing (PSB) · doi:10.1142/9789814749411_0037 · Cited by 94
Bazer, F. W., Burghardt, R. C., Johnson, G. A., Spencer, T. E., & Wu, G. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy047 · Cited by 94
A methionine-Mettl3-N-methyladenosine axis promotes polycystic kidney disease
Ramalingam, H., Kashyap, S., Cobo-Stark, P., Flaten, A., Chang, C.-M., Hajarnis, S. S., Hein, K. Z., Lika, J., Warner, G. M., Espíndola‐Netto, J. M., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.024 · Cited by 94
Lanning, N. J., Looyenga, B. D., Kauffman, A. L., Niemi, N. M., Sudderth, J., DeBerardinis, R. J., & MacKeigan, J. P. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.065 · Cited by 94
Targeting extracellular nutrient dependencies of cancer cells
García‐Bermúdez, J., Williams, R. T., Guarecuco, R., & Birsoy, K. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.11.011 · Cited by 93
Self-citationThe Role of D-3-Phosphoglycerate Dehydrogenase in Cancer
Zhao, X., Fu, J., Du, J., & Xu, W. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.41051 · Cited by 93
Metabolic requirements of pulmonary fibrosis: role of fibroblast metabolism
Hamanaka, R. B., & Mutlu, G. M. (2021) · FEBS Journal · doi:10.1111/febs.15693 · Cited by 94
Metadata
- Authors
- Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., Chen, W. W., Barrett, F. G., Stransky, N., Tsun, Z.-Y., Cowley, G. S., Barretina, J., Kalaany, N. Y., Hsu, P. P., Ottina, K., Chan, A. M., Yuan, B., Garraway, L. A., Root, D. E., Mino-Kenudson, M., Brachtel, E. F., Driggers, E. M., & Sabatini, D. M.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Agios Pharmaceuticals (United States) (US)
- Broad Institute (US)
- Harvard University (US)
- Corresponding author
- Sabatini, David M.
- ORCID
- Possemato, Richard
- Shaul, Yoav D.
- Pacold, Michael E.
- Kim, Dohoon
- Birsoy, Kıvanç
- Sethumadhavan, Shalini
- Jang, Hyun G.
- Jha, Abhishek K.
- Chen, Walter W.
- Barrett, Francesca G.
- Stransky, Nicolas
- Cowley, Glenn S.
- Barretina, Jordi
- Kalaany, Nada Y.
- Hsu, Peggy P.
- Yuan, Bingbing
- Garraway, Levi A.
- Root, David E.
- Mino-Kenudson, Mari
- Brachtel, Elena F.
- Sabatini, David M.
- Venue
- Nature
- Published
- 2011-08
- Volume
- 476
- Issue
- 7360
- Pages
- 346-350
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3353325
- OpenAlex
- W2022899908
- Cited by
- 1,683
- References
- 27
- Citations by year
- 2026: 72 · 2025: 111 · 2024: 120 · 2023: 116 · 2022: 138 · 2021: 167 · 2020: 137 · 2019: 126 · 2018: 93 · 2017: 97 · 2016: 125 · 2015: 93 · 2014: 109 · 2013: 72 · 2012: 87
- FWCI
- 31.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- RePEc: Research Papers in Economics (submittedVersion)
- PMC
- Funders
- Howard Hughes Medical Institute
- W. M. Keck Foundation
- Alexander and Margaret Stewart Trust
- Life Sciences Research Foundation
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- National Institutes of Health
- National Cancer Institute (CA103866, R01CA103866, R01CA129105)
- National Institute of General Medical Sciences (T32GM007753)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- PHGDH, breast cancer, cancer metabolism, breast cancer xenografts, estrogen receptor-negative breast cancer, alpha-ketoglutarate, glutamine metabolism, TCA cycle, anaplerosis, tumor metabolic reprogramming, anticancer drug targets, cell proliferation
- MeSH terms
- Animals, Breast Neoplasms, Citric Acid Cycle, Humans, Ketoglutaric Acids, Melanoma, Neoplasm Transplantation, Serine, Biomarkers, Tumor, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, Glutamic Acid, Genomics, RNA Interference, Cell Line, Tumor, Cell Proliferation, Phosphoglycerate Dehydrogenase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
